A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
The ADOPT-PGx study examined the impact of genotype-guided opioid prescribing on postoperative pain management. Results from the study were recently published in JAMA Network Open, accompanied by an invited commentary reflecting on the findings and their implications for pharmacogenetics in ...
Duke MEDx: CRISPR: Rewriting DNA And The Future Of Humanity
October 26, 2021 @ 4:00 pm - 5:00 pm
Join Duke MEDx to hear from Nobel Laureate Jennifer Doudna, PhD, on Tuesday, October 26, 2021, for the 2021 MEDx Distinguished Lecture. Lecture is from 4-5 pm ET on Zoom.